Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Glioblastoma chemotherapy ====== In [[2005]], a prospective, randomized, phase 3 trial by the European Organization for Research and Treatment of Cancer ([[EORTC]]) 26981-22981/National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) reported improved progression-free and overall survival for patients with Glioblastoma with the addition of concomitant and adjuvant [[temozolomide]] (TMZ), an oral alkylating agent, to [[radiotherapy]] (RT) following [[maximal safe resection]] ((Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for [[glioblastoma]]. N Engl J Med (2005) 352:987–96.10.1056/NEJMoa043330)). see [[Temozolomide for glioblastoma]]. glioblastoma_chemotherapy.txt Last modified: 2024/06/07 02:48by 127.0.0.1